Within the 2-year study period,as compared with placebo, everolimus slowed the increase in total kidney volume of patients with ADPKD but did not slow the progression of renal impairment [corrected]. (Funded by Novartis; EudraCT number, 2006-001485-16; ClinicalTrials.gov number, NCT00414440.)
Miniaturized and parallelized ligand binding assays are of great interest in postgenomic research because microarray technology allows the simultaneous determination of a large number of parameters from a minute amount of sample within a single experiment. Assay systems based on this technology are used for the identification and quantification of proteins as well as for the study of protein interactions. Protein affinity assays have been implemented that allow the analysis of interactions between proteins with other proteins, peptides, low molecular weight compounds, oligosaccharides or DNA. Microarray technology is an emerging technology used in global analytical approaches and has a considerable impact on proteomic research.
This paper explores the utility of data mining and machine learning algorithms for the induction of mutagenicity structure-activity relationships (SARs) from noncongeneric data sets. We compare (i) a newly developed algorithm (MOLFEA) for the generation of descriptors (molecular fragments) for noncongeneric compounds with traditional SAR approaches (molecular properties) and (ii) different machine learning algorithms for the induction of SARs from these descriptors. In addition we investigate the optimal parameter settings for these programs and give an exemplary interpretation of the derived models. The predictive accuracies of models using MOLFEA derived descriptors is ∼10-15%age points higher than those using molecular properties alone. Using both types of descriptors together does not improve the derived models. From the applied machine learning techniques the rule learner PART and support vector machines gave the best results, although the differences between the learning algorithms are only marginal. We were able to achieve predictive accuracies up to 78% for 10-fold cross-validation. The resulting models are relatively easy to interpret and usable for predictive as well as for explanatory purposes.
Nested dichotomies are a standard statistical technique for tackling certain polytomous classification problems with logistic regression. They can be represented as binary trees that recursively split a multi-class classification task into a system of dichotomies and provide a statistically sound way of applying two-class learning algorithms to multi-class problems (assuming these algorithms generate class probability estimates). However, there are usually many candidate trees for a given problem and in the standard approach the choice of a particular tree is based on domain knowledge that may not be available in practice. An alternative is to treat every system of nested dichotomies as equally likely and to form an ensemble classifier based on this assumption. We show that this approach produces more accurate classifications than applying C4.5 and logistic regression directly to multi-class problems. Our results also show that ensembles of nested dichotomies produce more accurate classifiers than pairwise classification if both techniques are used with C4.5, and comparable results for logistic regression. Compared to error-correcting output codes, they are preferable if logistic regression is used, and comparable in the case of C4.5. An additional benefit is that they generate class probability estimates. Consequently they appear to be a good generalpurpose method for applying binary classifiers to multi-class problems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.